We can offer a discount on bulk orders. Please contact our sales team for further inquiry.
Product Infomation
Product Name MAN-LNP@Citraconic acid, mannose-modified liposome loaded with citraconic acid
Catalog Number R-dz-8800
Alias Lucose-modified lipid nanoparticles@citraconic acid
Appearance Dispersion
Molecular Formula N/A
Solubility Ethanol, dimethyl sulfoxide
Storage 2-8°C, protected from light
Purity 95%+
Shelf Life 1 year
Shipping Condition low temperature transport
Application gene delivery
Specification 10mg:Inquiry
20mg:Inquiry
50mg:Inquiry
Description MAN-LNP@Citraconic acid is a new composite system that combines mannose-modified lipid nanoparticles with citraconic acid. Lipid nanoparticles (LNP) have good biocompatibility and drug-loading capacity, and can effectively package nucleic acids, small molecule drugs, etc. The modification of mannose (MAN) enables the system to specifically recognize the mannose receptor on the cell surface, thereby achieving targeted delivery and improving the enrichment efficiency of the drug in the target tissue or target cells. The introduction of citraconic acid gives the system acid-responsive characteristics. Citraconic acid is stable in neutral environments, but under acidic conditions such as tumor microenvironment, the chemical bonds modified by citraconic acid will break, prompting rapid release of the drug and achieving controlled release of the drug. This structural design enables it to show application potential in biomedical fields such as tumor targeted treatment and gene delivery.
Online Inquiry
For Research or Industrial Raw Materials, Not For Personal Medical Use!
Copyright © MATEXCEL. All Rights Reserved.
0
Inquiry Basket